Clinical trial
Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus…
NCT00171288 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171288 |
|---|---|
| Title | Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone |
| Official title | Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyslipidemia |
| Intervention type | Drug |
| Interventions | fluvastatin, ezetimibe |
| Enrollment | 83 |
| Start date | Aug 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 8, 2011 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: